Congress Park Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Congress Park Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $265,297 - $318,401	-790 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$284.6 - $344.99 $46,959 - $56,923	165 Added 26.4%	790 $273,000
Q1 2018 Apr 17, 2018	BUY	$315.82 - $393.78 $12,632 - $15,751	40 Added 6.84%	625 $215,000
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $209,798 - $274,920	585	585 $220,000

1,533

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Congress Park Capital LLC with notifications on news.